A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

Intra-arterial Allogeneic Mesenchymal Stem Cells for Critical Limb Ischemia are Safe and Efficacious: Report of a Phase I Study

(2013) Anjan Kumar Das et al.   WORLD JOURNAL OF SURGERY

Cellular Therapy With Ixmyelocel-T to Treat Critical Limb Ischemia: The Randomized, Double-blind, Placebo-controlled RESTORE-CLI Trial

(2012) Richard J Powell et al.   MOLECULAR THERAPY

Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia

(2011) Dirk H. Walter et al.   Circulation-Cardiovascular Interventions

Autologous Bone-Marrow Mononuclear Cell Implantation Reduces Long-Term Major Amputation Risk in Patients With Critical Limb Ischemia

(2011) Naomi Idei et al.   Circulation-Cardiovascular Interventions

Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial

(2011) Debin Lu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Beneficial Effects of VEGF Secreted from Stromal Cells in Supporting Endothelial Cell Functions: Therapeutic Implications for Critical Limb Ischemia

(2010) Gilda Cobellis et al.   CELL TRANSPLANTATION

Stem cell and progenitor cell therapy in peripheral artery disease

(2010) Peter Bramlage et al.   THROMBOSIS AND HAEMOSTASIS

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

(2009) Joshua M. Hare et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Intramuscular Transplantation of G-CSF-Mobilized CD34+Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single-Blinded, Dose-Escalation Clinical Trial

(2009) Atsuhiko Kawamoto et al.   STEM CELLS

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia

(2008) Satoaki Matoba et al.   AMERICAN HEART JOURNAL

Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature

(2008) P. Au et al.   BLOOD